Pfizer will study the effectiveness of its vaccine against COVID-19 by inoculating the whole population over the age of 12 in a town in southern Brazil, the company said on Wednesday.
The study will be conducted in Toledo, population 143,000, in the west of Parana state, together with Brazil's National Vaccination Program, local health authorities, a hospital and the federal university.
Pfizer said the purpose was to study the behaviour of COVID-19 in a "real life scenario" after the population has been vaccinated.
"The initiative is the first and only of its kind to be undertaken in a developing country in collaboration with the pharmaceutical company," it added.
Rescuers search for 130 people after Indonesia passenger ship sinks; six dead
Russian drone attack injures five in Ukraine's Odesa, officials say
Philippine ferry fire victims may take months to identify, authorities say
Israeli strike kills two people in Gaza, medics say
Saudi Arabia shuts key oil pipeline after drone attack
